Navigation Links
Tourette Syndrome Association Applauds the Passage of Genetic Information Nondiscrimination Act
Date:4/24/2008

Long-Awaited Legislation Will Protect Against Healthcare and Employment Discrimination

BAYSIDE, N.Y., April 24 /PRNewswire-USNewswire/ -- The national Tourette Syndrome Association, Inc. (TSA), hailed today's vote in the United States Senate approving comprehensive legislation, the Genetic Information Nondiscrimination Act (GINA), to ban genetic discrimination in health insurance and employment. The House of Representatives passed GINA in April 2007.

"TSA has worked alongside of the Genetic Alliance to call upon the Senate to support the procedural motions necessary to ensure the passage of this bill and today, we are very pleased with the passage of GINA in both the Senate and the House," said Judit Ungar, President of the Association. "For the past two decades TSA has been adamant in our support of patient rights and protection. The American people cannot afford to wait any longer for protection against genetic discrimination," she continued.

GINA (S. 358), would make it illegal for health insurers to raise premiums or deny coverage based on genetic information, and would prohibit employers from using such information for decisions on hiring, firing, promotions or job assignments. Genetic information, for the law's purposes, would include not only tests that determine variations in a person's DNA, but also a family history of a particular disease. But GINA does not prohibit discrimination once someone already has a disease, and some experts said such protection would have to be the next step. Passage of this initiative is crucial to ensuring the future of genetic research and the ability of all Americans to take advantage of genetic tests without fear that the information obtained will be used against them. "We attribute this historic victory to the bipartisan support for the bill. With each passing day, Congressional co-sponsors were being added to GINA, resulting with a record high roster of Congressional supporters, and
'/>"/>

SOURCE Tourette Syndrome Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Tourette Syndrome Association Celebrates the House Passage of LONG-AWAITED Mental Health Parity Legislation
2. James Marsden and Ashley & Jeffrey McDermott to Receive Honors at the Tourette Syndrome Association 2008 Champion of Children Awards Dinner
3. University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome
4. Metabolic Syndrome Triggered by Overeating, Not Obesity
5. Toxic Stock Syndrome Report: Many Companies Are Keeping Shareholders in the Dark on Potential Recalls, Bans, and Other Risks
6. AUDIO from Medialink and Apple Products Research and Education Council: New Research -- Adults Who Eat Apples, Apple Juice Have Healthier Diets and Lower Risk for Metabolic Syndrome
7. Leading experts investigate Shaken Baby Syndrome
8. Adults who eat apples, drink apple juice have lower risk for metabolic syndrome
9. Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic Syndrome
10. Clopidogrel reloading worthwhile in acute coronary syndromes
11. Data study suggests cortisol could alleviate for chronic fatigue syndrome and fibromyalgia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...re/ -- Harrington Physician Services (HPS) is plea...ysicians Martin Devine, Leah Doret, Elizabeth Full..., These four esteemed and popular Charlton-base...soon join the Harrington family in the new Harring... under construction at 10 North Main Street, at th...
(Date:11/30/2009)...registration of a visual stimulus by the unconscio...; between the time we see an apple and the time we...r eyes, but by how long? And how does this affect ...stimates say the time delay lasts only 100 millise... Tel Aviv University psychologists says that the a...
(Date:11/30/2009)...y designed program, study finds , , MOND...ve early intervention program for toddlers with au...s language and social skills, a new study shows. ,...able to learn and make remarkable progress," said ...hed online Nov. 30 in Pediatrics , and chief sci...
(Date:11/30/2009)...0 Sunlamps and tanning ...but the ultraviolet (UV) radiation from these devi...p://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...ves them a ,healthy, glow, any tan is a sign of sk...nd Drug Administration (FDA) scientist and interna...
(Date:11/30/2009)...Physicians at Beth Israel Deaconess Medical Center...onstrating the potential for automated analysis of...alyzer System® to assist in rapidly ruling ou...epartment (ED ) patients with chest pain. The abil...cCTA has potential to significantly reduce unneces...
Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3
... Texas, Nov. 6 The following was released today,b...eport from the U.S. Department of Veterans Affairs...1105-171) substantiated waste,mismanagement and in...ion to these serious disclosures constitutes viola...
... Net Sales increase 73% over Third Quarter 2007, ...Inc. (Nasdaq: ONXX ) today reported its financial...mber 30, 2008. Onyx reported net,income of $12.2 m...d in 2007. Excluding employee stock-based compensa...
...LOS, Calif., Nov. 6 Nektar,Therapeutics (Nasdaq: ...%, or,$100.0 million, of its outstanding convertib...for a total purchase price of $47.8 million. The,c...complete," said Nektar,President and CEO Howard W....
...errals should start with emergency room doctors, s...News) -- For children and teens who suffer violenc...oring on how to safely avoid conflict and diffuse ...ding gunshot, knife and fist-fight wounds -- at em...
... PfP Launches Ad Campaign Calli... , Washington, DC (PRWEB)...for Prevention said today that President-elect Oba...rdingly, the organization launched an ad campaign ...
...nce Call Scheduled for Today - Thursday, November ...tern Time, MOUNTAIN VIEW, Calif., Nov. 6 Alexza,...day financial results for,the quarter and nine mon...nded September 30, 2008, as reported in accordance...
Other Medicine News:Health News:War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 2Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 3Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 4Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 5Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 6Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 7Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 8Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 9Health News:Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2008 Financial Results 10Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 2Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 3Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 4Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 5Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 6Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 7Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 8Health News:Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results 9Health News:Counseling Can Combat Youth Violence 2Health News:Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 2Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 3Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 4Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 5Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 6Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 7Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 8Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 9Health News:Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates 10
(Date:11/30/2009)..., , COVINA, Calif., Nov. 30 /PRNewswire... and commercialization agreement with Academia Sin...n proprietary methods and Intellectual Property (I... stem cells. This method and IP was pioneered by ...ers of Academia Sinica. Professor Lin is currentl...
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNew...unced the completion of a Phase I study of CPSI-23... the production of TNF-alpha and other pro-inflamm...bility dose escalation study in healthy volunteers...inical testing. ,, All 30 enrolled subjects c...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNews...RG), the global authority on medical technology ma...facial injectable market declined by almost 5% ove...ent as a result of the economic crisis. The market...4, will return to the strong pre-recession growth ...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference 61862 1Why Holidays Dont Have To Be Happy 61860 1Why Holidays Dont Have To Be Happy 61860 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 1SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 3SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 4SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 5
...ImmuneRegen and TGen Continue Testing Possible Tre...apy Adjuvant Likely Targeting Adult Stem ... Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a ...,Inc. (OTC Bulletin Board: IRBO), today announced ... Services), an affiliate of The Translational,Geno...
...BRISBANE, Australia, Aug. 24 Physicians at Southe...designed to test the,efficacy of a new strategy fo...e toughest infectious diseases in the modern world..., which works as a,regulator of the body,s immune ...ion to patients with chronic hepatitis C viral inf...
Other Medicine Technology:ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4Drug in New Hepatitis C Clinical Trial 2
Sealing Mat for 384-well PCR plate
MicroAmp 24-Well Full Plate Covers
Eppendorf Sealing Mat 96
AlumaSeal Aluminum sealing film for multiwell plates
Medicine Products: